Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Maufras Du Chatellier, Elyssa

Investment Director

Charlotte Corbaz

Investment Drector - Large Venture

Dahoune, Sofia

Associate

Vanessa Giraud

Director of Environmental Impact Funds

Gwenaël Hamon

Investment Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Jacq, Véronique

Head of Digital Venture team

So-Yeon Koo

Senior Investment Manager

Eric Lefebvre

Director

Legardeur, Arnaud

Investment Director

Serge Mesguich

Director of FIT

Louis Molis

Investment Director

Adrien Neel

Investment Director

Gilles Schang

Deputy Managing Director

Past deals in Europe

Expliseat

Venture Round in 2023
Expliseat is a manufacturer specializing in lightweight aircraft seats, most notably the Titanium Seat, which weighs only 4 kg. This innovative design significantly reduces fuel consumption, yielding potential savings of up to $500,000 per aircraft annually. The seats are crafted from carbon fiber and feature a unique hinge mechanism, ensuring durability while accommodating passengers of all sizes. With ten patents to its name, Expliseat's products also enhance passenger comfort by providing two additional inches of legroom, catering to the evolving needs of airlines and their customers.

Alentis Therapeutics

Series C in 2023
Alentis Therapeutics, the CLDN1 company, is a clinical-stage biotech investigating novel therapeutics for CLDN1+ cancers. Alentis is the pioneering business in the use of anti-CLDN1 ADCs and antibodies to modify and reverse the progression of certain diseases.

Odimma

Seed Round in 2023
Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

EyeLights

Series A in 2023
EyeLights is a Head Up Display GPS. It allows motobikers to truly experience the ride by keeping their eyes on the road. Eyelights is the first universal motorcycle accessory that projects guidance, danger zones and traffic directly into your field of vision. A dangerous bend, a nearby stopper or speed over limitations, EyeLights warns you. Simple, uncluttered, they adapted the display for motorcycle riding. The EyeLights product installs in less than 5 minutes on your full-face, convertible or jet helmet. Their compact optical technology allows you to view your GPS more than 2 meters away while enjoying audio functions for more than 8 hours. The product is compatible with sun visors, insensitive to rain or fog and weighs less than 100g.

Kiro

Series A in 2023
Operator of a digital medicine company intended to provide insights on laboratory test results that are understandable to patients. The company fosters the interactions between laboratories, health professionals and patients and goes beyond results in patient care through the use of new technologies and artificial intelligence, enabling medical professionals to easily interpret and diagnose in a personalized and effective way.

Exotrail

Series B in 2023
Exotrail develops electric propulsion solutions for small satellites. Their safe and efficient Hall Effect Thrusters are helping build agile constellations to revolutionize telecommunication, earth observation, space, and science. David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz co-founded the company in Palaiseau, Ile-de-France in 2015.

Dianosic

Seed Round in 2023
Dianosic was founded in 2017 and develops cutting-edge solutions to resolve patient compliance challenges in Ear, Nose and Throat (ENT) conditions such as chronic allergic rhinitis and chronic sinusitis. Dianosic’s strategic goal is to establish new standards of care in chronic rhinitis and chronic sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This breakthrough formulation is developed with world renowned resorbable polymers experts. This long acting (6 to 12 months), steady releasing, patients and physicians' friendly, has the potential to establish new treatment paradigms. Noteworthy, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.

Garantme

Series B in 2023
Garantme gives access to thousands of international students in France by guaranteeing their lease and boosting their application.

ATAWEY

Private Equity Round in 2023
Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than a simple response: a solution that adapts to your uses. The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.

PASQAL

Series B in 2023
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

Agenium

Venture Round in 2023
Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.

Mycophyto

Venture Round in 2023
Co-created in July 2016 by Justine LIPUMA, PhD in microbiology, and Christine PONCET-DOISE, Senior Research Engineer at INRA, MYCOPHYTO is the result of 30 years of experimentation in biological crop protection.

Odaptos

Seed Round in 2023
Odaptos specializes in developing a software-as-a-service (SaaS) platform that facilitates usability testing in videoconferencing environments. This artificial intelligence-driven solution analyzes human emotions and user behavior, delivering comprehensive insights that help businesses understand their end-users. The platform streamlines the usability testing process by visually highlighting critical moments during interviews, thereby saving time and allowing for a more efficient evaluation of the user journey. Through its innovative approach, Odaptos aims to enhance user experience and optimize product development based on real-time feedback and analysis.

Kumulus Water

Pre Seed Round in 2022
Kumulus is the water utility company of the future with the mission of making drinking water accessible for all in a more economical and sustainable way. Kumulus builds machines that turn air into fresh mineralized drinking water.

Guerbet

Post in 2022
Guerbet is a human-scale company that aims to become a new global leader in medical imaging. Pioneer in contrast media with 90 years'​ experience, Guerbet is the only pharmaceutical group dedicated to medical imaging worldwide, with a presence in almost 80 countries via a network of subsidiaries and distributors. The company offers a comprehensive range of CT scan, Cath Lab, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostic (IRT) products, along with a range of injectors and related medical devices to improve patients'​ diagnosis, prognosis and quality of life.

ChapsVision

Venture Round in 2022
ChapsVision enables sectors with a large data footprint, such as Retail, Finance and Public Services, to successfully complete their digital transformation thanks to a highly complementary portfolio of business solutions fully integrated around a unified Customer and Product repository and a modern analysis and investigation platform.

Devialet

Venture Round in 2022
Devialet is an audio tech company that offers solutions ranging from ADH intelligence to sound amplification. The company's mission is to make Devialet audio technology universal. It has developed a pair of wireless earbuds called Gemini. The company was founded in 2007 and is based in Paris, Ile-de-France.

Apmonia Therapeutics

Venture Round in 2022
Apmonia Therapeutics developing a pipeline of next generation peptide based therapies targeting the tumor microenvironment to improve the lives of patients with cancer. If anyone would want to contact them please contact them via phone call or email.

Contentsquare

Series F in 2022
Contentsquare is an AI-powered platform that provides rich and contextual insight through customer behaviors, feelings, and intent. The platform helps brands to transform their businesses digitally using digital experience analytics that allows them to take action through enterprise scale and build customer trust with security, privacy, and accessibility.

Ludocare

Seed Round in 2022
Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Edaphos

Venture Round in 2022
Edaphos is an international holding company providing eco-friendly soil remediation solutions to transform waste and barren soil into fertile soil.

Flying Whales

Venture Round in 2022
Flying Whales is a French company founded in 2012, based in Suresnes, specializing in the development of large-capacity airships for the transport of heavy and oversized cargo. The company focuses on creating helium-filled, rigid-structure airships that can efficiently load and unload substantial freight from a stationary position. Utilizing small amounts of diesel and electric engines, Flying Whales aims to provide innovative solutions for transportation, logistics, and freight sectors facing infrastructure challenges. By enhancing freight transportation capabilities, the company helps clients reduce operating costs while minimizing environmental impact, effectively connecting land-locked regions to the global economy.

Healshape

Venture Round in 2022
Healshape creates natural breast reconstruction solutions for all women. Healshape is a biotech startup focused on regenerative medicine.

Siteflow

Series A in 2022
For many years digital transformation of the manufacturing industry has been underway. However, for regulated industries and operations that combine complex reporting workflows, project manufacturing and mobility for the field, few digital solutions meet the expectations. As a result, on those sites, tools and work methods haven’t changed so much the past decades while quality and safety requirements have exploded. That is around those challenges that professionnals from the nuclear industry, special works and software experts have gathered, to create Siteflow, the first cloud-based field service management software designed for complex operations (Nuclear, Oil&Gas…). A solution designed for end-user Beyond technical specificities from those markets, we have leveraged learnings from industries that have already been through digital transformation: every time user acceptance is key to make those challenging projects a success. This is why at Siteflow, our obsession is to design the most simple interfaces, and functionalities that bring value directly for our users, in order to simplify their daily tasks, to ease collaboration with their colleagues and to help them focus on what really matters. A change management program to facilitate digital transformation As we all know, the choice of a software solution is just part of the puzzle to implement a digital transformation program. Organizations need to be re-designed as day-to-day activities of engineers, project managers and operators are directly concerned. Based upon our experience, we help our customers for a smooth transition to operational excellence.

Osivax

Grant in 2022
​Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake into dendritic cells and increase the immunogenicity of the natural protein to trigger a more effective immune response, including an unprecedented CD8 T cell activation, enabling medical practitioners to treat patients with cancer as well as influenza, malaria and other infectious diseases effectively.

Leanspace

Debt Financing in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Strapi

Series B in 2022
Strapi is an open-source software helping developers to easily build, deploy, and manage APIs. Its open-source headless CMS provides backend functionality for applications and gives developers the freedom to use the tools of their choice for front-end frameworks. It’s called headless because the frontend is not part of the CMS, but there’s an API for content to show up on different devices. The company was founded in 2016 and headquartered in Paris, Ile-de-France.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

DCbrain

Venture Round in 2022
DCbrain is a deep-tech SaaS company that offers an optimization platform using AI and Hybrid AI algorithms intended for the energy and supply chain sector. Its platform supports AI, especially in the face of complex network configurations, to combine a visualization interface and a predictive analysis toolbox to help clients in identifying anomalies, preventing incidents, and predicting the future evolution of any network. The company was founded in 2014 and is headquartered in Paris, France.

Scintil Photonics

Venture Round in 2022
SCINTIL Photonics is a fabless company that develops silicon photonic integrated circuits. SCINTIL solutions combine the best of Silicon (Si) and Indium Phosphide (InP) materials using wafer-scale bonding of InP on Si and rely on commercial silicon foundry processes to build fully integrated photonic circuits (comprising multi-wavelength lasers, waveguides, wavelength filters, and photodetectors).

DBV Technologies

Post in 2022
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

Diabeloop

Debt Financing in 2022
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes. The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015 and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.

UnitySC

Venture Round in 2022
UnitySC specializes in metrology and inspection equipment for advanced semiconductor packaging and defect inspection. The company offers global service and application support to maintain equipment efficiency throughout its lifecycle. UnitySC serves various markets, including automotive, high-performance computing, and the Internet of Things, enhancing technological capabilities across industries.

Vade Secure

Venture Round in 2022
Vade Secure is the global leader on anti-phishing, spear phishing, malware and ransomware with heuristic filtering. Language independent, the filter analyzes globally all incoming emails (links, attached files, content…) to detect all threats in zero-day, even the most targeted attacks. After elimination all threats, we eliminate the nuisance of low priority emails with the Graymail Management. Ads, social networks notifications, and newsletters are automatically sent to the graymail folder while the Safe Unsubscribe button eliminate them forever. Protecting more than 500 million of mailboxes in 76 countries, our solutions are used by major ISPs, OEMs, and Enterprises worldwide. Vade Secure is implanted in 5 countries (USA, Canada, France, Hong Kong, and Japan) to offer a 24/7 support. For more information, please visit www.vadesecure.com/en.

Club Employes

Series A in 2022
Club Employes is an innovative web platform that offers hundreds of products, services at reduced prices to employees of French companies.

Arianee

Series A in 2022
Arianee is on a mission to allow brands and owners to bring products, experiences, and communities to life digitally through NFTs. We establish direct and continuing interactions via trust, respect, and honesty.

Sencrop

Series B in 2022
Sencrop is an ag-tech startup that offers an in-field data-based platform to empower farmers to make better decisions in their daily agricultural activities. Sencrop designs and sells connected weather forecast solutions for farmers to measure rain, hygrometry, and wind speed. The sensors are cheap, robust, movable, and easy to use, making more efficient and sustainable farming possible

Nutripure

Private Equity Round in 2022
Nutripure is a company based in Deyme, France, focused on the development and distribution of food supplements and organic superfoods. The business offers a diverse range of products, including protein bars, whey protein shakes, and peptides, aimed at helping customers achieve their health and wellness goals. As a Digital Native Vertical Brand, Nutripure emphasizes direct engagement with consumers, ensuring accessibility and quality in its offerings.

Implicity

Series A in 2022
Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac electronic implants. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alert taking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform.

mobee travel

Series A in 2022
Mobee travel is the first holiday booking plate form dedicated to reduced mobility people. We sell more than 30'000 accessibles accomodations all around the world and each of them are checked to ensure to our traveler's that everything's will be good for their needeed. If our traveler's need to have medical equipment during their trip, we provide them on the spot before their arrival.

Dfns

Seed Round in 2022
Dfns offers a wallets-as-a-service (WaaS) platform that enables businesses to efficiently manage digital assets while ensuring high levels of security. The platform integrates seamlessly with existing systems, allowing for secure user onboarding and streamlined transactions across multiple blockchains.

Ribonexus

Debt Financing in 2022
Ribonexus is a biotech specializing in the development of new therapies to combat cancer disease. Ribonexus, whose research and development programs are focused on the treatment of melanoma, is developing a pipeline of molecules that target the eukaryotic translation Initiation Factor-4A. (eIF4A). This target is active in a wide range of solid and hematologic cancers, including melanoma, and is linked to resistance to many current treatments. Ribonexus's goal is to deliver drugs that restore sensitivity to current targeted therapies in cancer patients who have become resistant to them.

Ribonexus

Grant in 2022
Ribonexus is a biotech specializing in the development of new therapies to combat cancer disease. Ribonexus, whose research and development programs are focused on the treatment of melanoma, is developing a pipeline of molecules that target the eukaryotic translation Initiation Factor-4A. (eIF4A). This target is active in a wide range of solid and hematologic cancers, including melanoma, and is linked to resistance to many current treatments. Ribonexus's goal is to deliver drugs that restore sensitivity to current targeted therapies in cancer patients who have become resistant to them.

Phagos

Pre Seed Round in 2022
phagos develops personalised bacteriophage solutions as a sustainable alternative to antibiotics.

Umiami

Series A in 2022
Umiami is a French food-tech startup that develops plant-based food technology to reduce meat consumption. It also offers plant-based whole-cuts that contain plant proteins helping consumers to have alternatives that mimic the taste, texture, and smell of meat. The company was founded in 2020 and is based in Paris, France.

LimFlow

Series D in 2022
LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularization efforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach.

Umiami

Series A in 2022
Umiami is a French food-tech startup that develops plant-based food technology to reduce meat consumption. It also offers plant-based whole-cuts that contain plant proteins helping consumers to have alternatives that mimic the taste, texture, and smell of meat. The company was founded in 2020 and is based in Paris, France.

Istya

Pre Seed Round in 2022
Istya develops solutions to monitor, predict and manage indoor air quality. Our solutions have also been designed to help reduce the energy cost of ventilation systems and limit the risk of spreading viruses by air. Istya was founded in 2021 and was headquartered in Ile-de-France, France.

Cairdac

Series A in 2022
Cairdac is a medtech startup that is creating on a self-sustaining leadless pacing system that uses an inertial energy harvester. The company used its assets and resources to become the first company in the world to successfully develop a self-sustaining pacemaker with a lifespan of more than 15 years. The use of a proprietary piezoelectric energy harvester in conjunction with its miniaturized ASIC "high-efficient power management circuit" enabled this energy performance. ALPSTM is a one-of-a-kind, autonomous, and endoscopically implanted leadless pacemaker with patented self-sustaining power technology that harvests the heart's kinetic energy. CAIRDAC applies disruptive technologies to traditional leadless pacemakers, meeting the growing needs of patients and healthcare professionals with an all-in-one, cost-effective solution that will revolutionize patients' quality of life.

Circle Sportswear

Seed Round in 2022
Circle Sportswear is a retailer that sells sportswear online. Sportswear is designed in a circular economy from recycled and recyclable fibres.

Deepki

Series C in 2022
Deepki supports real estate players in their transition to net zero and sustainability. To achieve this transition towards sustainability, Deepki helps realign stakeholders’ interests to build efficient strategies and transform real estate into a positive force for the planet. Deepki is the only company offering a fully populated ESG data intelligence platform combined with expert advisory services. The company’s end-to-end solutions leverage data to improve ESG performance and enhance the value of real estate assets.

Kayrros

Venture Round in 2022
Kayrros is the leading advanced data analytics company that helps global energy market players make better investment decisions. Kayrros experts extract value from the integration of alternative and market data into unique product offerings across the energy chain. With more than 100 employees representing over 15 nationalities working from headquarters in Paris and offices in Houston, London, New York and Singapore, Kayrros delivers actionable information in near real-time using cutting-edge technologies. Kayrros solutions are rapidly scalable and continually expanded to new geographies and new sources of data that help provide greater transparency into energy markets worldwide.

Vaxxel

Seed Round in 2022
Vaxxel is an Innovative viral live-attenuated platform that develops novel and proprietary live-attenuated vaccine candidates against bronchiolitis and pneumonia caused by pneumovirus.

Brenus Pharma

Seed Round in 2022
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.

Konect

Pre Seed Round in 2022
Konect helps users to create their own website and centralises all online content in one place and makes easy to share with community.

Archeon

Series A in 2022
Archeon is fully dedicated to the development of innovative solutions for the monitoring, diagnosis and treatment of critically ill patients in prehospital care.

K-Ryole

Series B in 2022
K-Ryole is a privately held company that specializes in the manufacture of smart electric bike trailers designed for cyclists. These innovative trailers can be attached to any bicycle and are capable of carrying heavy loads, making them suitable for urban transportation. By offering a practical solution for goods transport, K-Ryole aims to help riders reduce their carbon footprint while also lowering logistics costs.

Doctolib

Series F in 2022
Doctolib is an online healthcare booking platform and management software provider. For doctors, Doctolib offers a full-range service to improve bookings management, reduce no-show, and bring new patients to their office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctors or dental appointments 24/7 within a few clicks. Founded in 2013, Doctolib is based in Paris, France.

SeaBeLife

Grant in 2022
SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Flowlity

Seed Round in 2022
Poor inventory management accounts for billions in losses. Responding to this need, Flowlity brings resilient planning to prevent overstocks and shortages. Our ambition is to make supply chain plans resilient to uncertainty, and help you shift from a deterministic model to a resilient one. With a unique approach based on artificial intelligence and supply chain expertise, Flowlity has been helping leading companies, such as Danone, La Redoute, Saint Gobain and Camif to plan and forecast their inventories since 2018. Our customers see, on average, a reduction of 30% of their inventories and 20% of their shortages.

Alice & Bob

Series A in 2022
Alice&Bob build Universal, Error-free, Quantum Computers to help industries and researchers solve the hardest problems.

FidéCoin by FideClub

Debt Financing in 2022
RetailTech that offers the first loyalty currency on WhatsApp. We enable local businesses to join a loyalty program to allow their customers to earn FidéCoins when they make purchases. Everything happens on WhatsApp which allows the million users to have access to FidéCoin. We are incubated by Le Village by CA

Tenacy

Seed Round in 2022
The SaaS platform for better Compliance and Risk Management

Kyotherm

Venture Round in 2022
Kyotherm is an investment company that specializes in third-party financing of renewable heat production projects and energy efficiency projects. Kyotherm accompanies those that develop energy projects: energy service providers, engineering firms, developers, heat consumers, equipment manufacturers, etc., in securing third-party finance for their projects.

Lisaqua

Seed Round in 2022
Lisaqua is developing a unique aquaculture process to raise prawns without antibiotics and without polluting waste

Susu

Debt Financing in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

Susu

Grant in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

Kubo Labs

Pre Seed Round in 2022
94 % of organizations have experienced a serious security issue in the last 12 months and cluster misconfiguration is the leading cause ("Kubernetes adoption, security, and market trends report" by Redhat, July 2021). For 68% of the organizations, Kubernetes-related bills are going up ("FinOps for Kubernetes", CNCF report, June 2021). With Kubo Labs, we make sure that won't happen thanks to a series of products that embedded best-practices.

CarbonWorks

Series A in 2022
CarbonWorks is specialising in the use of microalgae to capture and utilise carbon dioxide.

Specify

Seed Round in 2022
Specify helps companies manage their brand identity, by collecting, storing, and distributing their design tokens and assets — automatically. Specify was founded in Paris (France) in 2018 by Valentin Chrétien, Pierre-Antoine Lemaître, Antoine Moreaux, and Louis Chenais. Formerly designers, product managers, and developers, these 4 co-founders decided to create Specify in order to revolutionize the way to maintain a brand's identity through different digital products. After 2 years of bootstrapping, and more than 1,000 international teams onboarded, Specify raises a $1m pre-seed with 360 Capital, BPI Seed Ventures, and Seedcamp. A few months later, Specify positions itself as the category leader for DesignOps and Design Systems by being the first Design Data Platform. In parallel, Specify is a member of the DTCG (Design Tokens Community Group) whose goal is to provide standards upon which products and design tools can rely for sharing stylistic pieces of a design system at scale.

Tracktor

Venture Round in 2022
Tracktor is a rental platform for construction workers, enabling them to rent out or borrow construction equipment in a few clicks.

Gouach

Seed Round in 2022
Gouach is a manufacturer of a revolutionary eco-designed battery that can be repaired at mega-speed.

Alma

Series C in 2022
Alma is a provider of installment-based payments through a large merchant network. It let customers pay in installments or later online or in-store.

Silvr

Series A in 2022
Silvr reinvents the way entrepreneurs get funded. Financing businesses has not evolved over the last decades: banks prefer to fund assets, and equity is not the best fit for all. Silvr enables entrepreneurs by building a world where funding is easy to access, scalable, and equity-free. Silvr leverages digital business data to predict future revenues and offer funding in 24 hours. Silvr is headquartered in Paris, is backed by ISAI and Eurazeo, and deploys millions of euros of funding for European entrepreneurs every month.

Traxens

Venture Round in 2022
TRAXENS delivers the world's most exhaustive, precise and timely information on containers and container transporters allowing all stakeholders in multi-modal transport to improve costs, optimize investment, and offer premium services. To attain this performance TRAXENS led a 3-year R&D program to develop specific technology required to produce cost effective, durable and autonomous devices for a wide range of container data capture and real-time transmission of this data from anywhere on the globe.

Elicit Plant

Series A in 2022
Elicit Plant is an agro-biotech company specializing in crops’ water resistance and the development of innovative phytosterol-based solutions. The company develops products that significantly reduce water stress in field-grown plants, making them better equipped to handle water shortages.

Combo

Series A in 2022
Combo is a staff planning and staff management software.

Ascor Communication

Venture Round in 2022
Ascor Communication is a holding company with private and family shareholders whose vocation is to invest in digital and distance learning.

Sextant

Series B in 2022
Sextant is a network of independent real estate agents specializing in property sales in France. With a strong focus on enhancing the customer experience, Sextant streamlines the purchasing process by managing all legal and financial aspects involved, ensuring a straightforward and stress-free experience for buyers and sellers. The company leverages technology by developing applications and websites that facilitate the work of its agents, reflecting its commitment to advancing the French Proptech sector. With less than a decade in the market, Sextant has established itself as a leader in real estate agent networks, effectively guiding clients from initial contact through to the signing of sale agreements at the notary.

Cureety

Series A in 2022
Cureety is a telemedicine startup that improves the follow-up and care of patients.

Starkage Therapeutics

Venture Round in 2022
Starkage Therapeutics is a discovery-stage biotechnology company. They also provide treatment for idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunction or hepatic fibroses.

NAWA Technologies

Series C in 2022
NAWATechnologies vision is to develop technologies that enable highly efficient energy transition, And the key to this is their Ultra Fast Carbon Battery Technology. At NAWATechnologies, they are developing new solutions that improve energy conversion, storage, transport and efficiency by using carbon as the material of choice. Carbon is abundant, accessible and naturally occurring. Minimizing the environmental impact of their manufacturing processes and improving the life cycle end of their products, by re-using, recovering and recycling is at the heart of what they do. Created in April 2013, NAWATechnologies benefits from over 15 years of R&D work on nanomaterials. Today, NAWA Technologies, strengthened by its 24 employees, has its own pilot production line and creates new interface materials and an innovative generation of ultracapacitors and batteries electrodes.

Wandercraft

Series C in 2022
Wandercraft develops and sells the first exoskeleton to walk self-balanced, providing a realistic gait without crutches or technical aids. Its first commercial version, Atalante, was CE-marked in 2019 and is sold to European rehab hospitals to improve gait re-learning treatments. As of June 2020, FDA approval is on the way. The company develops a slimmer, sleeker and agile Personal Mobility exo for daily life usage. Wandercraft is a full-stack company integrating competencies in algorithmics, AI, robotics, production, clinical, marketing and sales. Wandercraft's exo is the first realistic, autonomous walking device for the walking impaired and also likely the first bipedal walking robot to be a commercial product and not a lab prototype.

Figures

Venture Round in 2022
Figures provides real time compensation intelligence to companies, with the most extensive benchmark for European venture-backed companies.

Exotec

Series D in 2022
Exotec is the designer and manufacturer of the Goods to Person SKYPOD solution which enables order preparation in retail logistics in any sector of activity. The SKYPOD is a robotic order picking system but can also be used as a buffer solution for prepared orders and can be installed in cool or ambient environments. Upstream and downstream of SKYPOD, we customize according to the level of automation sought, according to the logistics characteristics and distribution channels of our customers. Our customers seek performance and flexibility in our solution: All our solutions are dimensioned as accurately as possible for the flow and stock required We can support the growth of the activity without interrupting production by simply adding robots, stations or racks

Heroic sante

Seed Round in 2022
Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

PayFit

Series E in 2022
PayFit offers technology that simplifies and automates payroll and HR processes for small and medium-sized businesses. It provides users the visibility and automation they need to easily manage payroll, with the support of payroll experts. The company supports the digital transformation of businesses through a growing range of product features and services.

Groupe SFC

Venture Round in 2022
• A team of 200 employees including 18 associates, providing daily guidance to more than 5000 clients • 9 locations in France • Our policy is geared towards quality and customer satisfaction • Understanding of technology which guarantees the use of high-performance and specialised solutions • Experts to drive forward your performance, at all stages of your company’s life • In 2012, turnover of close to €14.5m

Pherecydes Pharma

Grant in 2022
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Stern Tech

Seed Round in 2022
We created a revolutionary SaaS platform for human behavior analysis: AI x Psychology to understand human behavior in real time. Use cases: Marketing, Education, eMeetings, Healthcare, Automotive, Retail, Sport. See our partnership with Renault and STMicroelectronics : https://stern.consulting/sterntech-h1stvision.mp4

Fysali

Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.

Kovalee

Seed Round in 2021
Kovalee is a mobile app publisher that supports app creators by providing a comprehensive application publishing platform. The company partners with app owners to elevate their apps in the marketplace, offering services such as product enhancement, user acquisition, monetization, and app store optimization. Kovalee's platform features modular design and application testing, enabling developers to focus on content and code while leveraging data-driven strategies. Additionally, the company employs artificial intelligence to predict customer behavior, helping developers optimize their apps for better performance and profitability.

Depixus

Series A in 2021
Depixus includes a Full genome analysis, which necessitates technologies capable of reading DNA, RNA, and their base changes. The dynamics of this cannot be captured with single-molecule precision by today's sequencing technology.

Meiogenix

Series A in 2021
Meiogenix is a biotech company developing breeding technologies to unlock the unexplored genetic diversity of organisms. Meiogenix expands the natural biodiversity and helps to develop new products to address global food and industrial challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.